AbSci Announces Acquisition of Target Discovery Company Totient

AbSci Announces Acquisition of Target Discovery Company Totient

VANCOUVER, Wash., June 14, 2021 /PRNewswire/ — AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced the acquisition of Totient, a discovery company harnessing human immune responses to identify...